Project Details
Description
A Phase 3, INterVentional, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of DCC-2618 In Patients with Advanced c-KIT/PDGFRA Gastrointestinal Stromal TUmorS who have Received Prior Treatment with Imatinib, Sunitinib, and/or Rego
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/17 → 5/31/21 |
Funding
- DECIPHERA PHARMACEUTICALS, LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.